June 1, 2020 • 12:00am EDT. Aurinia Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference Read Press Release View All News Find the latest Aurinia Pharmaceuticals Inc (AUPH) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Protalix BioTherapeutics, Inc. PLX 3.42 0.20 (5.55%). NYSEMkt Updated Jun 5, 2020 9:08 PM Sorrento Therapeutics Inc. SRNE 4.72 0.60 (14.56%). NASDAQ Updated Jun 8, 2020 8:00 PM AUPH | Complete Aurinia Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Aurinia Pharmaceuticals Inc. (AUPH) is pleased to announce that the nine incumbent directors of the Company were elected at the Company’s annual general meeting held on June 2, 2020. Detailed results of the vote by proxy for the election of directors are provided below: All other matters voted on at the Meeting were also approved. Aurinia Submits FDA New Drug Admission For Novel Voclosporin Kidney Treatment. Shares in Aurinia Pharmaceuticals, Inc (AUPH) advanced in pre-market trading as the biotech company announced the

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) Aurinia Pharmaceuticals is having an incredibly strong start to the trading session today. When the opening bell rang, the stock was already trading well …

Aurinia Pharmaceuticals Inc (AUPH) Stock Message Board ... Aurinia is a late-stage biopharmaceutical company providing novel products specifically engineered to treat a limited, targeted patient population suffering from serious disease states for which there is a high unmet medical need. Aurinia Pharmaceuticals Inc. (AUPH) Stocktalk | Seeking Alpha Read the latest StockTalks, investment ideas, and community discussion on Aurinia Pharmaceuticals Inc. (AUPH).

Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.

May 14, 2019 Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Stock ...

Find the latest Aurinia Pharmaceuticals Inc (AUPH) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) issued its quarterly earnings results on Thursday, May, 14th. The biotechnology company reported ($0.15) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.20) by $0.05. AUPH - Aurinia Pharmaceuticals Inc Stock quote - CNNMoney.com Find real-time AUPH - Aurinia Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Breaking News: AUPH latest news. - The Fly Reports Q1 revenue $30,000, consensus $50,000. "We are fortunate that the global COVID-19 pandemic has had minimal impact on Aurinia's operations, and we have maintained our timelines to ensure the filing of the voclosporin NDA by the end of the second quarter and hopefully obtain approval in early 2021," commented Peter Greenleaf, President and Chief Executive Officer of Aurinia. AUPH Stock News - Fidelity

Jun 05, 2020

June 1, 2020 • 12:00am EDT. Aurinia Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference Read Press Release View All News Find the latest Aurinia Pharmaceuticals Inc (AUPH) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Protalix BioTherapeutics, Inc. PLX 3.42 0.20 (5.55%). NYSEMkt Updated Jun 5, 2020 9:08 PM Sorrento Therapeutics Inc. SRNE 4.72 0.60 (14.56%). NASDAQ Updated Jun 8, 2020 8:00 PM AUPH | Complete Aurinia Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

• 外汇百万富翁叶庆熙的秘密pdf下载
• 欧元交易员ka25
• ins crypto reddit
• Verizon股票目标价格
• 外汇交易平台联系电话
• pypl股票图
• 晨星基金评论
• drjwrit
• drjwrit
• drjwrit